Treatment of Perioral Dermatitis Driven by Topical Skin Products
Perioral dermatitis is a facial skin condition in which ongoing use of topical products — cosmetics, soaps, moisturisers, and similar preparations — plays a central role in sustaining the disorder. The first-line therapeutic approach is built around systematically removing these exogenous factors.
Clinical Situation
This protocol applies to perioral dermatitis where suspected topical skin products are the primary perpetuating factor. Therapeutic management begins by identifying and stopping all such exposures, including cosmetics, cleansers, moisturisers, abrasives, astringents, and similar preparations.
Treatment Approach (partial overview)
The protocol centres on a structured elimination strategy — stopping all suspected topical exposures and replacing them with a minimal, defined approach to facial cleansing. Specific guidance is also included for managing the rebound skin reaction that commonly follows discontinuation.
The complete patient instructions, sequencing, and management steps for rebound phenomena are in the full regimen.
Treatment Goals
The aim is gradual disappearance of all symptoms and progressive clearing of the facial skin as exogenous factors are stopped. Patients should be counselled that improvement unfolds over several weeks and that the skin regresses slowly once triggers are removed.
References
DOI: 10.1016/j.clindermatol.2013.05.034
- The first step in the therapeutic management of PD should be the discontinuation of all suspected topical treatments, although this usually leads to relapse of the skin lesion.
- The physician should insist on the abandonment of all cosmetics, soaps, detergents, moisturizers, abrasives, astringents, day or night creams, and skin conditioners.
- The patient should be told to wash with mild water only; some authors suggest the use of fingers.
- This "null (zero) therapy" is hard for many patients to follow, so local neutral treatments involving neutral local creams and compresses (eg, chamomile tea, physiologic solution) may be used.
- Some investigators treat patients with rebound phenomena with hydrocortisone, which reduces the violence of the rebound reaction while allowing the atrophic collagen to recover.
- Others taper the dose of topical corticosteroids by reducing the frequency of administration.
- There is gradual disappearance of all symptoms, and relapses are rare unless corticosteroids are repeatedly administered.
- Patients have to be told that exacerbations are to be expected, that it may take many weeks for the skin to clear, and that the disease slowly regresses when exogenous factors are stopped.
View source ↗